DCM
ZBH icon

Davis Capital Management’s Zimmer Biomet ZBH Stock Holding History

Davis Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$775 Buy
9
+7
+350% +$614 ﹤0.01% 531
2026
Q1 		$181 Sell
2
-2
-50% -$184 ﹤0.01% 558
2025
Q4 		$360 Buy
4
+2
+100% +$190 ﹤0.01% 462
2025
Q3 		$197 Buy
+2
New +$198 ﹤0.01% 575

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Davis Capital Management's ZBH Position: Q2 2026 in Review

Davis Capital Management increased its Zimmer Biomet (ZBH) stake by 350% in Q2 2026, buying an estimated $614 and bringing the position to 9 shares worth $775. The position accounts for ﹤0.01% of the portfolio, ranked #531.

Davis Capital Management first reported a position in ZBH in Q3 2025 and has held it in 4 quarters since. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Davis Capital Management held 9 shares of Zimmer Biomet worth $775 as of Q2 2026.
  • Davis Capital Management bought 7 Zimmer Biomet shares in Q2 2026, an estimated $614.
  • Zimmer Biomet made up ﹤0.01% of Davis Capital Management's portfolio in Q2 2026, its #531 holding.
  • Davis Capital Management first reported a position in Zimmer Biomet in Q3 2025 and has held it in 4 quarters since.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.